Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1352, 2002-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Ormrod D. Wellington K. Wagstaff A.J.
Drugs, Vol. 62, Iss. 14, 2002-01 ,pp. :
Standard chemo plus docetaxel does not compromise QOL
Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. :
Docetaxel added to standard chemotherapy does not compromise QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 515, 2006-01 ,pp. :
Sorafenib therapy does not compromise the QOL of patients with renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 516, 2006-01 ,pp. :